Comparative Effectiveness Research and Formulary Placement: The Case of Diabetes
Formularies of the future should use evidence-produced CER to better target, not limit, diabetes care.
Competitive Bidding in Medicare: Who Benefits From Competition?
Competitive bidding characterizes market-based proposals to control Medicare spending, but in this first empirical study of bidding in Medicare, we find that competition is lacking.
Slowing Medicare Spending Growth: Reaching for Common Ground
Recognizing shared features of 2 Medicare payment reform strategies, premium support and global payment, may help us focus on, and resolve, the differences.
State-Level Impacts of Medicare Part D
Bending the Curve Through Health Reform Implementation
Authors from The Brookings Institution update their recommendations by focusing on 3 concrete objectives to slow spending and improve quality of care within the next 5 years.
Geographic Correlation Between Large-Firm Commercial Spending and Medicare Spending
Traditional Medicare and the large-firm commercial sector have a positive correlation in hospital utilization, but a lack of correlation in spending.
Value-Based Insurance Design: Embracing Value Over Cost Alone
Bending the Curve: Effective Steps to Address Long-Term Healthcare Spending Growth
A group of experts who have spent their careers studying the healthcare system have convened to identify a path for sustainable reform in healthcare cost growth.
Value Based Insurance Design: Maintaining a Focus on Health in an Era of Cost Containment
In this commentary, our Co-Editors-in-Chief advocate valuebased principles that align incentives to encourage use of high value services as an important tool in healthcare reform.
Utilization Outcomes and Patient Cost Sharing
What Does the RAND Health Insurance Experiment Tell Us About the Impact of Patient Cost Sharing on Health Outcomes?
Value-based insurance design may reduce the adverse consequences of cost sharing, as well as support quality improvement initiatives.
"Fiscally Responsible, Clinically Sensitive" Cost Sharing: Contain Costs While Preserving Quality
Value-based Insurance Design: Aligning Incentives to Bridge the Divide Between Quality Improvement and Cost Containment
Rising Out-of-pocket Costs in Disease Management Programs
Value-based Insurance Design: A "Clinically Sensitive" Approach to Preserve Quality of Care and Contain Costs
Univariate Solutions in a Multivariate World: Can We Afford to Practice as in the "good old days"?
Achieving Value in Healthcare
Advocacy and Remedies for Healthcare Disparities
Taking Stock at 2 Years - Continuing the Journey
A Word From the New Editors
Diagnostic Testing or Empirical Neuraminidase Inhibitor Therapy for Patients with Influenza-Like Illness: What a Difference a Day Makes
A New Method for Determining Patient Payments for Outpatient Drugs
A Benefit-Based Copay for Prescription Drugs: Patient Contribution Based on Total Benefits, Not Drug Acquisition Cost
Decomposing Pharmaceutical Cost Growth in Different Types of Health Plans
Understanding the Behavioral Response to Medical Innovation
Correspondence regarding, "Diagnosis and Eradication of Helicobacter pylori in the Management of Peptic Ulcer Disease: A Decision Analysis Model"
